Related Experiment Videos
Somatic growth in infants receiving prolonged caffeine therapy.
J C Le Guennec1, F Sitruk, C Breault
1Department of Pediatrics, University of Sherbrooke, Province of Quebec, Canada.
Acta Paediatrica Scandinavica
|January 1, 1990
Summary
Prolonged caffeine therapy in premature infants did not negatively impact growth. Regular assessments showed consistent increases in weight, length, and head circumference during and after treatment.
Area of Science:
- Neonatal Medicine
- Pediatric Growth Studies
Background:
- Caffeine is commonly used to treat apnea of prematurity.
- Concerns exist regarding the long-term effects of prolonged caffeine administration on infant development.
Purpose of the Study:
- To evaluate the impact of prolonged caffeine therapy on the longitudinal growth of premature infants.
- To assess physical growth parameters including length, weight, and head circumference.
Main Methods:
- Longitudinal growth evaluation of 28 premature infants receiving prolonged caffeine therapy (mean 23.8 weeks).
- Regular physical examinations and measurements (length, weight, head circumference) at multiple time points: start, mid, end of therapy, and 3 and 6 months post-therapy.
- Statistical analysis using analysis of variance (ANOVA).
Main Results:
- Infants demonstrated regular increases in weight, length, and head circumference throughout the study period.
- Growth parameters followed expected developmental trajectories on standard growth curves.
- Analysis of variance indicated highly significant growth (p < 0.0001).
Conclusions:
- Prolonged caffeine therapy in premature infants does not appear to adversely affect key growth parameters.
- The findings suggest that caffeine treatment is safe concerning early infant physical development.